Hogy Medical Co.,Ltd. revised earnings guidance for the full year ended March 31, 2021. For the full year, the company expects net sales to be ¥36,310 million against previous guidance of ¥38,700 million. Operating income is expected to be ¥5,490 million against previous guidance of ¥6,400 million. Profit attributable to owners of parent is expected to be ¥4,980 million against previous guidance of ¥5,300 million. Profit per share is expected to be ¥164.70 against previous guidance of ¥175.28.